At the Women in Pharma® breakfast panel discussion on Powerful Leadership held at the ISPE Facility of the Future Conference, 7 - 8 February in San Francisco, California, five speakers offered perspectives on leadership and team building. The information they shared is universally applicable to both managers and individual contributors; an examination of what makes and good leader and how to become one.
To quote one panelist: “Leadership is about others, not an individual activity.” A great leader develops and works with their team to accomplish goals. It takes time and effort to develop talent but pays dividends when individuals have the confidence, autonomy, and tools to succeed.
One method that great managers use to develop their team is to give them exposure to hard problems. The best managers give opportunities to their team and reward initiative which helps create new leaders.
A panelist remarked that, “A leader needs to have the courage to walk through a door without knowing what is on the other side.” This courage comes from building a strong team that is well-trained and prepared.
We all have a hand in developing leaders by sharing our experience to help others learn and build skills to use in their careers and in everyday life. Watch and listen to how good leaders’ direct people, include others in conversation, see that goals are met, and ensure that credit is given where credit is due. Over time, we can learn to implement these skills to make our own contributions at home and in life impactful and valuable.
I’m excited for the next Women in Pharma® breakfast panel discussion to be held at the 2019 ISPE Biopharmaceutical Manufacturing Conference in Boston, Massachusetts on 18 – 20 June in Boston, MA USA. Panelists include biopharma leaders who will share their insights on achieving and the value of gender balance in biomanufacturing. In addition, there will be an opportunity for attendees to participate in breakout group discussions.
This session is open to everyone – even if you’re not able to attend the conference.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...